2025 Annual Meeting | C113 - Clinical EMG 1: Nerve Conduction Studies and Needle EMG: Patterns in Neuromuscular Disorders

Date Monday 04/07/25

Time 01:00 PM - 03:00 PM PDT Add To Calendar

Location San Diego Convention Center | 10

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Kelly G. Gwathmey, MD

Topic(s) Neuromuscular and Clinical Neurophysiology (EMG)

Learning Objectives Participants should be able to demonstrate how to approach a neuromuscular patient electrodiagnostically and utilize nerve conduction studies and needle examination to: evaluate a weak patient to discern myopathy, neuromuscular junction, or motor neuron disorders; distinguish characteristics of peripheral neuropathy; and elucidate EDX findings in mononeuropathies and radiculopathies. The program will build upon electrodiagnostic knowledge acquired in Clinical EMG I.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge, Quality Improvement

Program Level Introductory

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Medical Student

Teaching Styles Case-based, Didactic, Audience Participation

Program Materials Program Evaluations

Event Timeline
01:00 PM - 01:05 PM PDT	Introduction	Introduction Kelly G. Gwathmey, MD
01:05 PM - 01:35 PM PDT	Speaker	Approach to Nerve Conduction Studies Kelly G. Gwathmey, MD
01:35 PM - 02:10 PM PDT	Speaker	Nerve Conduction Studies: Clinical Patterns in Neuromuscular Disorders Ruple S. Laughlin, MD, FAAN
02:10 PM - 02:45 PM PDT	Speaker	Needle EMG: Clinical Patterns in Neuromuscular Disorders Aaron E. Izenberg, MD
02:10 PM - 03:10 PM PDT	Q&A	Questions and Answers Kelly G. Gwathmey, MD, Ruple S. Laughlin, MD, FAAN, Aaron E. Izenberg, MD

Faculty Disclosures
Kelly G. Gwathmey, MD	Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Strongbridge. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Gwathmey has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion Pharmaceuticals.
Ruple S. Laughlin, MD, FAAN	Dr. Laughlin has nothing to disclose.
Aaron E. Izenberg, MD	Dr. Izenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Izenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Izenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genzyme. Dr. Izenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexxion. Dr. Izenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for alnylam.

��ɫ��

��ɫ��